Allspring Global Investments Holdings, LLC Lyell Immunopharma, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$1.45 - $3.35 $17,969 - $41,516	12,393 New	12,393 $18,000
Q2 2023 Jul 18, 2023	BUY	$1.89 - $3.86 $8,516 - $17,393	4,506 Added 55.73%	12,592 $40,000
Q1 2023 Apr 13, 2023	BUY	$1.97 - $3.58 $12,820 - $23,298	6,508 Added 412.42%	8,086 $19,000
Q4 2022 Jan 23, 2023	SELL	$2.78 - $8.09 $38,894 - $113,187	-13,991 Reduced 89.86%	1,578 $0
Q3 2022 Oct 26, 2022	BUY	$5.54 - $8.27 $86,252 - $128,755	15,569 New	15,569 $114,000

Others Institutions Holding LYEL

# of Institutions

121

Shares Held

142M

Call Options Held

18.1K

Put Options Held

200

Mwg Management Ltd. Washington, DC

20.2M
Shares

$12.3 Million
30.81% of portfolio
Apoletto LTD Washington, DC

15.1M
Shares

$9.21 Million
42.56% of portfolio
Orland Properties LTD Washington, DC

15.1M
Shares

$9.21 Million
13.96% of portfolio
Black Rock Inc. New York, NY

13.5M
Shares

$8.23 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$6.14 Million
0.0% of portfolio

View Full List

About Lyell Immunopharma, Inc.

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $151M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

More about LYEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account